Clinical Trial Update: Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase I/II trial evaluating AZD8931 in combination with Paclitaxel for advanced solid tumors and advanced breast cancer. The study completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• AZD8931 (AZD8931)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasms, Breast Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-29